Get the Stockscreener App
1.44
3.97%
+0.055
Nexalin Technology Inc stock is currently priced at $1.44, with a 24-hour trading volume of 72,601.
It has seen a +3.97% increased in the last 24 hours and a +132.26% rose in the past month.
The chart indicates a potential bullish trend, as the stock is above the $1.40 pivot point. If it approaches the $1.45 resistance level, significant changes may occur.
Previous Close:
$1.385
Open:
$1.45
24h Volume:
72,601
Market Cap:
$10.71M
Revenue:
$128.60K
Net Income/Loss:
$-4.60M
P/E Ratio:
-4.1143
EPS:
-0.35
Net Cash Flow:
$-3.74M
1W Performance:
+0.70%
1M Performance:
+132.26%
6M Performance:
+323.53%
1Y Performance:
+73.68%
1D Range:
$1.41
$1.54
52W Range:
$0.2528
$3.40
Nexalin Technology Inc Stock (NXL) Company Profile
Name
Nexalin Technology Inc
Sector
Industry
Phone
713 660 1100
Address
1776 Yorktown, Suite 550, Houston
Nexalin Technology Inc Stock (NXL) Latest News
Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements
GlobeNewswire Inc.
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Nexalin Technology Awarded Key Patent Related to its Gen-3 HALO Clarity™, a Non-Invasive, Frequency-Based Deep-Brain Stimulation Device
GlobeNewswire Inc.
Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Nexalin Technology Announces the Appointment of Government Affairs Veteran William A. Hudson, Jr. to Military & Government Advisory Board
GlobeNewswire Inc.
Nexalin Technology Commences Sales of Gen-2 Neurostimulation Device to New Mental Health Center in Oman Dedicated to Nexalin’s Technology
GlobeNewswire Inc.
Nexalin Technology Inc Stock (NXL) Financials Data
Nexalin Technology Inc (NXL) Revenue 2024
NXL reported a revenue (TTM) of $128.60 thousand for the quarter ending September 30, 2023, a -90.16% decline year-over-year.
Nexalin Technology Inc (NXL) Net Income 2024
NXL net income (TTM) was -$4.60 million for the quarter ending September 30, 2023, a -189.71% decrease year-over-year.
Nexalin Technology Inc (NXL) Cash Flow 2024
NXL recorded a free cash flow (TTM) of -$3.74 million for the quarter ending September 30, 2023, a -117.53% decrease year-over-year.
Nexalin Technology Inc (NXL) Earnings per Share 2024
NXL earnings per share (TTM) was -$0.63 for the quarter ending September 30, 2023, a -95.65% decline year-over-year.
About Nexalin Technology Inc
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. It also engages in the development of Generation 2, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiates, chronic pain, Alzheimer's disease, and dementia. The company was incorporated in 2021 and is headquartered in Houston, Texas.
1.69%
0.48%
Cap:
|
Volume (24h):